Status:

COMPLETED

Vitamin D in Preschoolers With Viral-induced Asthma

Lead Sponsor:

St. Justine's Hospital

Collaborating Sponsors:

The Hospital for Sick Children

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Conditions:

Asthma

Eligibility:

All Genders

1-5 years

Phase:

PHASE2

PHASE3

Brief Summary

In this 7-month randomized controlled trial, children aged 1-6 years with asthma attacks triggered mostly by colds, will receive a high dose of vitamin D or a placebo every 3.5 months during their usu...

Detailed Description

IMPORTANT NOTE: Due to receiving a 2-year partial funding enabling only a single-centre pilot trial, rather than an adequately-powered multicentre study, the primary outcome was modified post hoc for ...

Eligibility Criteria

Inclusion

  • age 1-5 years
  • physician-diagnosed asthma as per the Global Initiative for Asthma (GINA) guidelines
  • URTIs as the main asthma trigger (parental report)
  • ≥4 URTIs in the past 12 months (parental report)
  • ≥1 asthma exacerbation requiring rescue oral corticosteroids (OCS) in the past 6 months or ≥2 in the past 12 months

Exclusion

  • intake or intention to use more than 400 IU/day of vitamin D supplement
  • extreme prematurity (\<28 weeks gestation)
  • infants \<12 months of age
  • no vitamin D supplementation when breast-fed
  • recent (\<1 year) immigrants from a region at high risk of rickets
  • children with vitamin D restrictive diets e.g. vegans
  • other chronic respiratory disease (broncho-pulmonary dysplasia; cystic fibrosis)
  • condition(s) that alter calcium or vitamin D metabolism/absorption (hypo/hyperparathyroidism, kidney/liver disease, inflammatory bowel disease)
  • medications that interfere with vitamin D metabolism (anti-epileptics, diuretics, antacids, anti-fungal drug)
  • vitamin D supplementation \>1000 IU/ day in last 3 months
  • anticipated difficult follow-up (unable to attend clinic visits; plan to leave the province).

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2016

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT02197702

Start Date

September 1 2014

End Date

July 1 2016

Last Update

December 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Sainte Justine

Montreal, Quebec, Canada, H3T1C5